Literature DB >> 28842183

Pronounced and sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of neurotransmitters released from sympathetic nerves.

Kevin M Christmas1, Jordan C Patik2, Sepideh Khoshnevis3, Kenneth R Diller3, R Matthew Brothers4.   

Abstract

Cryotherapy is a therapeutic technique using ice or cold water applied to the skin to manage soft tissue trauma and injury. While beneficial, there are some potentially detrimental side effects, such as pronounced vasoconstriction and tissue ischemia that are sustained for hours post-treatment. This study tested the hypothesis that this vasoconstriction is mediated by 1) activation of post-synaptic α-adrenergic receptors and/or 2) activation of post-synaptic neuropeptide Y1 (NPY Y1) receptors. 8 subjects were fitted with a commercially available cryotherapy unit with a water perfused bladder on the lateral portion of the right calf. Participants were instrumented with four intradermal microdialysis probes beneath the bladder. The following conditions were applied at the four treatment sites: 1) control (Ringer solution), 2) combined post-synaptic β-adrenergic receptors and neuropeptide (NPY) Y1 receptors blockade (P+B site), 3) combined post-synaptic α-adrenergic receptor, β-adrenergic receptor, and NPY Y1 receptor blockade (Y+P+B site), and 4) blockade of pre-synaptic release of all neurotransmitters from the sympathetic nerves (BT site). Following thermoneutral baseline data collection, 1°C water was perfused through the bladder for 30min, followed by passive rewarming for 60min. Skin temperature (Tskin) fell from ~34°C to ~18.5°C during active cooling across all sites and there was no difference between sites (P>0.05 vs. control for each site). During passive rewarming Tskin rose to a similar degree in all sites (P>0.05 relative to the end of cooling). In the first 20min of cooling %CVC was reduced at all sites however, this response was blunted in the BT and the Y+P+B sites (P>0.05 for all comparisons). By the end of cooling the degree of vasoconstriction was similar between sites with the exception that the reduction in %CVC in the Y+B+P site was less relative to the reduction in the control site. %CVC was unchanged in any of the sites during passive rewarming such that each remained similar to values obtained at the end of active cooling. These findings indicate that the initial vasoconstriction (i.e. within the 1st 20min) that occurs during cryotherapy induced local cooling is achieved via activation of post-synaptic α-adrenergic receptors; whereas nonadrenergic mechanisms predominate as the duration of cooling continues. The sustained vasoconstriction that occurs following cessation of the cooling stimulus does not appear to be related to activation of post-synaptic α-adrenergic receptors or NPY Y1 receptor.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryotherapy; Ischemia; Skin-surface cooling; Soft tissue injury; Vasoconstriction

Mesh:

Substances:

Year:  2017        PMID: 28842183      PMCID: PMC5681365          DOI: 10.1016/j.mvr.2017.08.005

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  42 in total

1.  Cryotherapy-induced nerve injury.

Authors:  F H Bassett; J S Kirkpatrick; D L Engelhardt; T R Malone
Journal:  Am J Sports Med       Date:  1992 Sep-Oct       Impact factor: 6.202

2.  Cryotherapy-Induced Persistent Vasoconstriction After Cutaneous Cooling: Hysteresis Between Skin Temperature and Blood Perfusion.

Authors:  Sepideh Khoshnevis; Natalie K Craik; R Matthew Brothers; Kenneth R Diller
Journal:  J Biomech Eng       Date:  2016-03       Impact factor: 2.097

3.  Mechanisms of vasoconstriction with direct skin cooling in humans.

Authors:  John M Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-01-19       Impact factor: 4.733

4.  The involvement of nitric oxide in the cutaneous vasoconstrictor response to local cooling in humans.

Authors:  Gary J Hodges; Kun Zhao; Wojciech A Kosiba; John M Johnson
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

5.  Sustained cutaneous vasoconstriction during and following cyrotherapy treatment: Role of oxidative stress and Rho kinase.

Authors:  Kevin M Christmas; Jordan C Patik; Sepideh Khoshnevis; Kenneth R Diller; R Matthew Brothers
Journal:  Microvasc Res       Date:  2016-04-14       Impact factor: 3.514

6.  Common peroneal neuropathy related to cryotherapy and compression in a footballer.

Authors:  Terence Babwah
Journal:  Res Sports Med       Date:  2011-01       Impact factor: 4.674

7.  Sympathetic, sensory, and nonneuronal contributions to the cutaneous vasoconstrictor response to local cooling.

Authors:  John M Johnson; Tony C Yen; Kun Zhao; Wojciech A Kosiba
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-02       Impact factor: 4.733

8.  Local ascorbate administration augments NO- and non-NO-dependent reflex cutaneous vasodilation in hypertensive humans.

Authors:  Lacy A Holowatz; W Larry Kenney
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-05-04       Impact factor: 4.733

9.  Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.

Authors:  Masao Takemoto; Jianxin Sun; Junko Hiroki; Hiroaki Shimokawa; James K Liao
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

10.  The involvement of norepinephrine, neuropeptide Y, and nitric oxide in the cutaneous vasodilator response to local heating in humans.

Authors:  Gary J Hodges; Wojciech A Kosiba; Kun Zhao; John M Johnson
Journal:  J Appl Physiol (1985)       Date:  2008-05-15
View more
  2 in total

1.  A COMPREHENSIVE REHABILITATION PROGRAM FOR TREATING LATERAL ELBOW TENDINOPATHY.

Authors:  Joseph M Day; Ann M Lucado; Timothy L Uhl
Journal:  Int J Sports Phys Ther       Date:  2019-09

2.  Assessment of the Dynamics of Temperature Changes in the Knee Joint Area in Response to Selected Cooling Agents in Thermographic Tests.

Authors:  Aleksandra Radecka; Waldemar Pluta; Anna Lubkowska
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.